Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2020

Open Access 01-12-2020 | Insulins | Original investigation

Association of insulin resistance, from mid-life to late-life, with aortic stiffness in late-life: the Atherosclerosis Risk in Communities Study

Authors: Anna K. Poon, Michelle L. Meyer, Hirofumi Tanaka, Elizabeth Selvin, James Pankow, Donglin Zeng, Laura Loehr, Joshua W. Knowles, Wayne Rosamond, Gerardo Heiss

Published in: Cardiovascular Diabetology | Issue 1/2020

Login to get access

Abstract

Background

Insulin resistance may contribute to aortic stiffening that leads to end-organ damage. We examined the cross-sectional association and prospective association of insulin resistance and aortic stiffness in older adults without diabetes.

Methods

We analyzed 2571 men and women at Visit 5 (in 2011–2013), and 2350 men and women at repeat examinations from baseline at Visit 1 (in 1987–1989) to Visit 5 (in 2011–2013). Linear regression was used to estimate the difference in aortic stiffness per standard unit of HOMA-IR, TG/HDL-C, and TyG at Visit 5. Linear mixed effects were used to assess if high, as opposed to non-high, aortic stiffness (> 75th percentile) was preceded by a faster annual rate of change in log-HOMA-IR, log-TG/HDL-C, and log-TyG from Visit 1 to Visit 5.

Results

The mean age of participants was 75 years, 37% (n = 957) were men, and 17% (n = 433) were African American. At Visit 5, higher HOMA-IR, higher TG/HDL-C, and higher TyG were associated with higher aortic stiffness (16 cm/s per SD (95% CI 6, 27), 29 cm/s per SD (95% CI 18, 40), and 32 cm/s per SD (95% CI 22, 42), respectively). From Visit 1 to Visit 5, high aortic stiffness, compared to non-high aortic stiffness, was not preceded by a faster annual rate of change in log-HOMA-IR from baseline to 9 years (0.030 (95% CI 0.024, 0.035) vs. 0.025 (95% CI 0.021, 0.028); p = 0.15) or 9 years onward (0.011 (95% CI 0.007, 0.015) vs. 0.011 (95% CI 0.009, 0.013); p = 0.31); in log-TG/HDL-C from baseline to 9 years (0.019 (95% CI 0.015, 0.024) vs. 0.024 (95% CI 0.022, 0.026); p = 0.06) or 9 years onward (− 0.007 (95% CI − 0.010, − 0.005) vs. − 0.009 (95% CI − 0.010, − 0.007); p = 0.08); or in log-TyG from baseline to 9 years (0.002 (95% CI 0.002, 0.003) vs. 0.003 (95% CI 0.003, 0.003); p = 0.03) or 9 years onward (0 (95% CI 0, 0) vs. 0 (95% CI 0, 0); p = 0.08).

Conclusions

Among older adults without diabetes, insulin resistance was associated with aortic stiffness, but the putative role of insulin resistance in aortic stiffness over the life course requires further study.
Appendix
Available only for authorised users
Literature
1.
go back to reference Reaven G. Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol. 2012;32:1754–9.PubMedCrossRef Reaven G. Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol. 2012;32:1754–9.PubMedCrossRef
2.
go back to reference Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;1988(37):1595–607.CrossRef Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;1988(37):1595–607.CrossRef
3.
go back to reference Folsom A, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt J. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk In Communities (Aric) Study. Diabetes Care. 1997;20:935–42.PubMedCrossRef Folsom A, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt J. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk In Communities (Aric) Study. Diabetes Care. 1997;20:935–42.PubMedCrossRef
4.
go back to reference Willette A, Xu G, Johnson S, Birdsill A, Jonaitis E, Sager M, Hermann B, La Rue A, Asthana S, Bendlin B. Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care. 2013;36:443–9.PubMedPubMedCentralCrossRef Willette A, Xu G, Johnson S, Birdsill A, Jonaitis E, Sager M, Hermann B, La Rue A, Asthana S, Bendlin B. Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care. 2013;36:443–9.PubMedPubMedCentralCrossRef
6.
go back to reference Safar ME. Pulse pressure, arterial stiffness, and cardiovascular risk. Curr Opin Cardiol. 2000;15:258–63.PubMedCrossRef Safar ME. Pulse pressure, arterial stiffness, and cardiovascular risk. Curr Opin Cardiol. 2000;15:258–63.PubMedCrossRef
7.
go back to reference Loehr L, Meyer M, Poon AK, Selvin E, Palta P, Tanaka H, Pankow J, Wright J, Griswold M, Wagenknecht L, Heiss G. Prediabetes and diabetes are associated with arterial stiffness in older adults: the Aric study. Am J Hypertens. 2016;29:1038–45.PubMedPubMedCentralCrossRef Loehr L, Meyer M, Poon AK, Selvin E, Palta P, Tanaka H, Pankow J, Wright J, Griswold M, Wagenknecht L, Heiss G. Prediabetes and diabetes are associated with arterial stiffness in older adults: the Aric study. Am J Hypertens. 2016;29:1038–45.PubMedPubMedCentralCrossRef
8.
go back to reference Webb DR, Khunti K, Silverman R, Gray LJ, Srinivasan B, Lacy PS, Williams B, Davies MJ. Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity. Diabetologia. 2010;53:1190–8.PubMedCrossRef Webb DR, Khunti K, Silverman R, Gray LJ, Srinivasan B, Lacy PS, Williams B, Davies MJ. Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity. Diabetologia. 2010;53:1190–8.PubMedCrossRef
9.
go back to reference Bhuiyan A, Srinivasan S, Chen W, Paul T, Berenson G. Correlates of vascular structure and function measures in asymptomatic young adults: the Bogalusa Heart Study. Atherosclerosis. 2006;189:1–7.PubMedCrossRef Bhuiyan A, Srinivasan S, Chen W, Paul T, Berenson G. Correlates of vascular structure and function measures in asymptomatic young adults: the Bogalusa Heart Study. Atherosclerosis. 2006;189:1–7.PubMedCrossRef
10.
go back to reference Park J, Nam J, Cho M, Yoo J, Ahn C, Jee S, Lee H, Cha B, Kim K, Lee H. Insulin resistance independently influences arterial stiffness in normoglycemic normotensive postmenopausal women. Menopause. 2010;17:779–84.PubMed Park J, Nam J, Cho M, Yoo J, Ahn C, Jee S, Lee H, Cha B, Kim K, Lee H. Insulin resistance independently influences arterial stiffness in normoglycemic normotensive postmenopausal women. Menopause. 2010;17:779–84.PubMed
11.
go back to reference Urbina E, Khoury P, Mccoy C, Dolan L, Daniels S, Kimball T. Triglyceride to Hdl-C ratio and increased arterial stiffness in children, adolescents, and young adults. Pediatrics. 2013;131:e1082–90.PubMedPubMedCentralCrossRef Urbina E, Khoury P, Mccoy C, Dolan L, Daniels S, Kimball T. Triglyceride to Hdl-C ratio and increased arterial stiffness in children, adolescents, and young adults. Pediatrics. 2013;131:e1082–90.PubMedPubMedCentralCrossRef
12.
go back to reference Khoshdel AR, Eshtiaghi R. Assessment of arterial stiffness in metabolic syndrome related to insulin resistance in apparently healthy men. Metab Syndr Relat Disord. 2019;17:90–6.PubMedCrossRef Khoshdel AR, Eshtiaghi R. Assessment of arterial stiffness in metabolic syndrome related to insulin resistance in apparently healthy men. Metab Syndr Relat Disord. 2019;17:90–6.PubMedCrossRef
13.
go back to reference Defronzo R, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–23.PubMed Defronzo R, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–23.PubMed
14.
go back to reference Bonora E, Targher G, Alberiche M, Bonadonna R, Saggiani F, Zenere M, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63.PubMedCrossRef Bonora E, Targher G, Alberiche M, Bonadonna R, Saggiani F, Zenere M, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63.PubMedCrossRef
15.
go back to reference Staten M, Stern M, Miller W, Steffes M, Campbell S. Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care. Diabetes Care. 2010;33:205–6.PubMedPubMedCentralCrossRef Staten M, Stern M, Miller W, Steffes M, Campbell S. Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care. Diabetes Care. 2010;33:205–6.PubMedPubMedCentralCrossRef
16.
go back to reference Mclaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, Simon J, Krauss R. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96:399–404.PubMedCrossRef Mclaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, Simon J, Krauss R. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96:399–404.PubMedCrossRef
17.
go back to reference Guerrero-Romero F, Simental-Mendia L, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala M, Hernandez-Gonzalez S, Jacques-Camarena O, Rodriguez-Moran M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347–51.PubMedCrossRef Guerrero-Romero F, Simental-Mendia L, Gonzalez-Ortiz M, Martinez-Abundis E, Ramos-Zavala M, Hernandez-Gonzalez S, Jacques-Camarena O, Rodriguez-Moran M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347–51.PubMedCrossRef
18.
go back to reference Zhang M, Wang B, Liu Y, Sun X, Luo X, Wang C, Li L, Zhang L, Ren Y, Zhao Y, Zhou J, Han C, Zhao J, Hu D. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: the Rural Chinese Cohort Study. Cardiovasc Diabetol. 2017;16:30.PubMedPubMedCentralCrossRef Zhang M, Wang B, Liu Y, Sun X, Luo X, Wang C, Li L, Zhang L, Ren Y, Zhao Y, Zhou J, Han C, Zhao J, Hu D. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: the Rural Chinese Cohort Study. Cardiovasc Diabetol. 2017;16:30.PubMedPubMedCentralCrossRef
19.
go back to reference The Aric Investigators. The atherosclerosis risk in communities (Aric) study: design and objectives. Am J Epidemiol. 1989;129:687–702.CrossRef The Aric Investigators. The atherosclerosis risk in communities (Aric) study: design and objectives. Am J Epidemiol. 1989;129:687–702.CrossRef
20.
go back to reference Parrinello C, Grams M, Couper D, Ballantyne C, Hoogeveen R, Eckfeldt J, Selvin E, Coresh J. Recalibration of blood analytes over 25 years in the atherosclerosis risk in communities study: impact of recalibration on chronic kidney disease prevalence and incidence. Clin Chem. 2015;61:938–47.PubMedPubMedCentralCrossRef Parrinello C, Grams M, Couper D, Ballantyne C, Hoogeveen R, Eckfeldt J, Selvin E, Coresh J. Recalibration of blood analytes over 25 years in the atherosclerosis risk in communities study: impact of recalibration on chronic kidney disease prevalence and incidence. Clin Chem. 2015;61:938–47.PubMedPubMedCentralCrossRef
21.
go back to reference Poon AK, Meyer M, Reaven G, Knowles J, Selvin E, Pankow J, Couper D, Loehr L, Heiss G. Short-term repeatability of insulin resistance indexes in older adults: the Atherosclerosis Risk In Communities Study. J Clin Endocrinol Metab. 2018;103:2175–81.PubMedPubMedCentralCrossRef Poon AK, Meyer M, Reaven G, Knowles J, Selvin E, Pankow J, Couper D, Loehr L, Heiss G. Short-term repeatability of insulin resistance indexes in older adults: the Atherosclerosis Risk In Communities Study. J Clin Endocrinol Metab. 2018;103:2175–81.PubMedPubMedCentralCrossRef
22.
go back to reference CSCC. Manual 2, Appendix 17: pulse wave unit instruction manual. CSCC. Manual 2, Appendix 17: pulse wave unit instruction manual.
23.
24.
go back to reference Rizopoulos D. JM: an R package for the joint modelling of longitudinal and time-to-event data. J Stat Softw. 2010;35:1–33.CrossRef Rizopoulos D. JM: an R package for the joint modelling of longitudinal and time-to-event data. J Stat Softw. 2010;35:1–33.CrossRef
25.
go back to reference Seo HS, Kang TS, Park S, Park HY, Ko YG, Choi D, Jang Y, Chung N. Insulin resistance is associated with arterial stiffness in nondiabetic hypertensives independent of metabolic status. Hypertens Res. 2005;28:945–51.PubMedCrossRef Seo HS, Kang TS, Park S, Park HY, Ko YG, Choi D, Jang Y, Chung N. Insulin resistance is associated with arterial stiffness in nondiabetic hypertensives independent of metabolic status. Hypertens Res. 2005;28:945–51.PubMedCrossRef
26.
go back to reference Fu S, Lin Y, Luo L, Ye P. Relationship between central arterial stiffness and insulin resistance in chinese community-dwelling population without diabetes mellitus. Int J Endocrinol. 2017;2017:1073919.PubMedPubMedCentralCrossRef Fu S, Lin Y, Luo L, Ye P. Relationship between central arterial stiffness and insulin resistance in chinese community-dwelling population without diabetes mellitus. Int J Endocrinol. 2017;2017:1073919.PubMedPubMedCentralCrossRef
27.
go back to reference Gottsater M, Ostling G, Persson M, Engstrom G, Melander O, Nilsson PM. Non-hemodynamic predictors of arterial stiffness after 17 years of follow-up: the malmo diet and cancer study. J Hypertens. 2015;33:957–65.PubMedPubMedCentralCrossRef Gottsater M, Ostling G, Persson M, Engstrom G, Melander O, Nilsson PM. Non-hemodynamic predictors of arterial stiffness after 17 years of follow-up: the malmo diet and cancer study. J Hypertens. 2015;33:957–65.PubMedPubMedCentralCrossRef
28.
go back to reference Ho CT, Lin CC, Hsu HS, Liu CS, Davidson LE, Li TC, Li CI, Lin WY. Arterial stiffness is strongly associated with insulin resistance in chinese—a population-based study (Taichung Community Health Study, Tchs). J Atheroscler Thromb. 2011;18:122–30.PubMedCrossRef Ho CT, Lin CC, Hsu HS, Liu CS, Davidson LE, Li TC, Li CI, Lin WY. Arterial stiffness is strongly associated with insulin resistance in chinese—a population-based study (Taichung Community Health Study, Tchs). J Atheroscler Thromb. 2011;18:122–30.PubMedCrossRef
29.
go back to reference Lee SB, Ahn CW, Lee BK, Kang S, Nam JS, You JH, Kim MJ, Kim MK, Park JS. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol. 2018;17:41.PubMedPubMedCentralCrossRef Lee SB, Ahn CW, Lee BK, Kang S, Nam JS, You JH, Kim MJ, Kim MK, Park JS. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol. 2018;17:41.PubMedPubMedCentralCrossRef
30.
go back to reference Nakanishi N, Shiraishi T, Wada M. Brachial-ankle pulse wave velocity and metabolic syndrome in a japanese population: the Minoh study. Hypertens Res. 2005;28:125–31.PubMedCrossRef Nakanishi N, Shiraishi T, Wada M. Brachial-ankle pulse wave velocity and metabolic syndrome in a japanese population: the Minoh study. Hypertens Res. 2005;28:125–31.PubMedCrossRef
31.
go back to reference Lambrinoudaki I, Kazani MV, Armeni E, Georgiopoulos G, Tampakis K, Rizos D, Augoulea A, Kaparos G, Alexandrou A, Stamatelopoulos K. The Tyg Index as a marker of subclinical atherosclerosis and arterial stiffness in lean and overweight postmenopausal women. Heart Lung Circ. 2018;27:716–24.PubMedCrossRef Lambrinoudaki I, Kazani MV, Armeni E, Georgiopoulos G, Tampakis K, Rizos D, Augoulea A, Kaparos G, Alexandrou A, Stamatelopoulos K. The Tyg Index as a marker of subclinical atherosclerosis and arterial stiffness in lean and overweight postmenopausal women. Heart Lung Circ. 2018;27:716–24.PubMedCrossRef
32.
go back to reference Won KB, Park GM, Lee SE, Cho IJ, Kim HC, Lee BK, Chang HJ. Relationship of insulin resistance estimated by triglyceride glucose index to arterial stiffness. Lipids Health Dis. 2018;17:268.PubMedPubMedCentralCrossRef Won KB, Park GM, Lee SE, Cho IJ, Kim HC, Lee BK, Chang HJ. Relationship of insulin resistance estimated by triglyceride glucose index to arterial stiffness. Lipids Health Dis. 2018;17:268.PubMedPubMedCentralCrossRef
33.
go back to reference Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gender Med. 2009;6(Suppl 1):60–75.CrossRef Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gender Med. 2009;6(Suppl 1):60–75.CrossRef
34.
go back to reference Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiologica. 2011;203:259–69.PubMedCrossRef Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiologica. 2011;203:259–69.PubMedCrossRef
35.
go back to reference Facchini F, Humphreys MH, Jeppesen J, Reaven GM. Measurements of insulin-mediated glucose disposal are stable over time. J Clin Endocrinol Metab. 1999;84:1567–9.PubMed Facchini F, Humphreys MH, Jeppesen J, Reaven GM. Measurements of insulin-mediated glucose disposal are stable over time. J Clin Endocrinol Metab. 1999;84:1567–9.PubMed
36.
go back to reference Mceniery CM, Wilkinson IB, Johansen NB, Witte DR, Singh-Manoux A, Kivimaki M, Tabak AG, Brunner EJ, Shipley MJ. Nondiabetic glucometabolic status and progression of aortic stiffness: the Whitehall Ii Study. Diabetes Care. 2017;40:599–606.PubMedPubMedCentralCrossRef Mceniery CM, Wilkinson IB, Johansen NB, Witte DR, Singh-Manoux A, Kivimaki M, Tabak AG, Brunner EJ, Shipley MJ. Nondiabetic glucometabolic status and progression of aortic stiffness: the Whitehall Ii Study. Diabetes Care. 2017;40:599–606.PubMedPubMedCentralCrossRef
37.
go back to reference Lambadiari V, Pavlidis G, Kousathana F, Varoudi M, Vlastos D, Maratou E, Georgiou D, Andreadou I, Parissis J, Triantafyllidi H, Lekakis J, Iliodromitis E, Dimitriadis G, Ikonomidis I. Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes. Cardiovasc Diabetol. 2018;17:8.PubMedPubMedCentralCrossRef Lambadiari V, Pavlidis G, Kousathana F, Varoudi M, Vlastos D, Maratou E, Georgiou D, Andreadou I, Parissis J, Triantafyllidi H, Lekakis J, Iliodromitis E, Dimitriadis G, Ikonomidis I. Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes. Cardiovasc Diabetol. 2018;17:8.PubMedPubMedCentralCrossRef
38.
go back to reference Sakura T, Morioka T, Shioi A, Kakutani Y, Miki Y, Yamazaki Y, Motoyama K, Mori K, Fukumoto S, Shoji T, Emoto M, Inaba M. Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2017;16:62.PubMedPubMedCentralCrossRef Sakura T, Morioka T, Shioi A, Kakutani Y, Miki Y, Yamazaki Y, Motoyama K, Mori K, Fukumoto S, Shoji T, Emoto M, Inaba M. Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2017;16:62.PubMedPubMedCentralCrossRef
39.
go back to reference Aroor AR, Das NA, Carpenter AJ, Habibi J, Jia G, Ramirez-Perez FI, Martinez-Lemus L, Manrique-Acevedo CM, Hayden MR, Duta C, Nistala R, Mayoux E, Padilla J, Chandrasekar B, Demarco VG. Glycemic control by the Sglt2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury. Cardiovasc Diabetol. 2018;17:108.PubMedPubMedCentralCrossRef Aroor AR, Das NA, Carpenter AJ, Habibi J, Jia G, Ramirez-Perez FI, Martinez-Lemus L, Manrique-Acevedo CM, Hayden MR, Duta C, Nistala R, Mayoux E, Padilla J, Chandrasekar B, Demarco VG. Glycemic control by the Sglt2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury. Cardiovasc Diabetol. 2018;17:108.PubMedPubMedCentralCrossRef
40.
go back to reference Abbott RD, Sharp DS, Burchfiel CM, Curb JD, Rodriguez BL, Hakim AA, Yano K. Cross-sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: the Honolulu Heart Program. Ann Epidemiol. 1997;7:417–24.PubMedCrossRef Abbott RD, Sharp DS, Burchfiel CM, Curb JD, Rodriguez BL, Hakim AA, Yano K. Cross-sectional and longitudinal changes in total and high-density-lipoprotein cholesterol levels over a 20-year period in elderly men: the Honolulu Heart Program. Ann Epidemiol. 1997;7:417–24.PubMedCrossRef
41.
go back to reference Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkand BM, Schonfeld G, Jacobs D, Frantz ID Jr. Lipoprotein-cholesterol distributions in selected north american populations: the lipid research clinics program prevalence study. Circulation. 1980;61:302–15.PubMedCrossRef Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkand BM, Schonfeld G, Jacobs D, Frantz ID Jr. Lipoprotein-cholesterol distributions in selected north american populations: the lipid research clinics program prevalence study. Circulation. 1980;61:302–15.PubMedCrossRef
42.
go back to reference Park YM, Sui X, Liu J, Zhou H, Kokkinos PF, Lavie CJ, Hardin JW, Blair SN. The effect of cardiorespiratory fitness on age-related lipids and lipoproteins. J Am Coll Cardiol. 2015;65:2091–100.PubMedPubMedCentralCrossRef Park YM, Sui X, Liu J, Zhou H, Kokkinos PF, Lavie CJ, Hardin JW, Blair SN. The effect of cardiorespiratory fitness on age-related lipids and lipoproteins. J Am Coll Cardiol. 2015;65:2091–100.PubMedPubMedCentralCrossRef
43.
go back to reference Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol. 1994;49:M252–7.PubMedCrossRef Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol. 1994;49:M252–7.PubMedCrossRef
44.
go back to reference Willett W, Hennekens CH, Castelli W, Rosner B, Evans D, Taylor J, Kass EH. Effects of cigarette smoking on fasting triglyceride, total cholesterol, and HDL-cholesterol in women. Am Heart J. 1983;105:417–21.PubMedCrossRef Willett W, Hennekens CH, Castelli W, Rosner B, Evans D, Taylor J, Kass EH. Effects of cigarette smoking on fasting triglyceride, total cholesterol, and HDL-cholesterol in women. Am Heart J. 1983;105:417–21.PubMedCrossRef
45.
go back to reference Airaksinen KE, Salmela PI, Linnaluoto MK, Ikaheimo MJ, Ahola K, Ryhanen LJ. Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen. Cardiovasc Res. 1993;27:942–5.PubMedCrossRef Airaksinen KE, Salmela PI, Linnaluoto MK, Ikaheimo MJ, Ahola K, Ryhanen LJ. Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen. Cardiovasc Res. 1993;27:942–5.PubMedCrossRef
46.
go back to reference Prenner SB, Chirinos JA. Arterial stiffness in diabetes mellitus. Atherosclerosis. 2015;238:370–9.PubMedCrossRef Prenner SB, Chirinos JA. Arterial stiffness in diabetes mellitus. Atherosclerosis. 2015;238:370–9.PubMedCrossRef
Metadata
Title
Association of insulin resistance, from mid-life to late-life, with aortic stiffness in late-life: the Atherosclerosis Risk in Communities Study
Authors
Anna K. Poon
Michelle L. Meyer
Hirofumi Tanaka
Elizabeth Selvin
James Pankow
Donglin Zeng
Laura Loehr
Joshua W. Knowles
Wayne Rosamond
Gerardo Heiss
Publication date
01-12-2020
Publisher
BioMed Central
Keywords
Insulins
Insulins
Published in
Cardiovascular Diabetology / Issue 1/2020
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-020-0986-y

Other articles of this Issue 1/2020

Cardiovascular Diabetology 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.